Entamoeba Histolytica
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
First Report of Entamoeba Moshkovskii in Human Stool Samples From
Kyany’a et al. Tropical Diseases, Travel Medicine and Vaccines (2019) 5:23 https://doi.org/10.1186/s40794-019-0098-4 SHORT REPORT Open Access First report of Entamoeba moshkovskii in human stool samples from symptomatic and asymptomatic participants in Kenya Cecilia Kyany’a1,2* , Fredrick Eyase1,2, Elizabeth Odundo1, Erick Kipkirui1, Nancy Kipkemoi1, Ronald Kirera1, Cliff Philip1, Janet Ndonye1, Mary Kirui1, Abigael Ombogo1, Margaret Koech1, Wallace Bulimo1 and Christine E. Hulseberg3 Abstract Entamoeba moshkovskii is a member of the Entamoeba complex and a colonizer of the human gut. We used nested polymerase chain reaction (PCR) to differentiate Entamoeba species in stool samples that had previously been screened by microscopy. Forty-six samples were tested, 23 of which had previously been identified as Entamoeba complex positive by microscopy. Of the 46 specimens tested, we identified nine (19.5%) as E. moshkovskii-positive. In seven of these nine E. moshkovskii-positive samples, either E. dispar or E. histolytica (or both) were also identified, suggesting that co-infections may be common. E. moshkovskii was also detected in both symptomatic and asymptomatic participants. To the best of our knowledge, this is the first report of E. moshkovskii in Kenya. Keywords: Entamoeba, Entamoeba moshkovskii, Diarrhea, Kenya, Nested PCR Introduction was isolated from both symptomatic and asymptomatic Entamoeba moshkovskii is a member of the Entamoeba participants [7]. A 2012 study by Shimokawa and collegues complex and is morphologically indistinguishable from E. [11] pointed to the possible pathogenicity of E. moshkovskii dispar and the pathogenic E. histolytica.WHOrecom- as a cause of diarrhea in mice and infants. -
Product Information Sheet for NR-2597
Product Information Sheet for NR-2597 Entamoeba histolytica 200:NIH Clone 1 nitrogen carrier is preferred. Please read the following recommendations prior to using this material. Catalog No. NR-2597 Growth Conditions: Growth Media: (Derived from ATCC® 50555™) ATCC medium 2154: or equivalent Incubation: For research use only. Not for human use. Temperature: 35–37°C Atmosphere: Axenic and microaerophilic Contributor: Propagation: ATCC® 1. To establish a culture from the frozen state, place a vial in a 35°C water bath for 2 to 3 minutes, until thawed. Product Description: Immerse the vial just enough to cover the frozen Protozoa Classification: Entamoebidae, Entamoeba material. Do not agitate the vial. Agent: Entamoeba histolytica 2. Transfer the vial contents to a 16 x 125 mm screw- Strain: 200:NIH Clone 1 capped borosilicate glass test tube containing 13 mL of 1 ® Source: Strain 200:NIH (ATCC 30458™) monoxenized and growth medium. cloned via microisolation, then reaxenized 3. Screw the cap on tightly and incubate at a 15° horizontal Comments: Entamoeba histolytica 200:NIH was deposited at slant at 35°C. Observe the culture daily and subculture ® 2-5 ATCC in 1975 by Dr. Louis S. Diamond , Laboratory of when peak trophozoite density is observed. Parasitic Diseases, National Institute of Allergy and 4. To subculture, ice the culture for 10 minutes and gently Infectious Diseases, National Institutes of Health, invert 20 times. Bethesda, Maryland. 5. Aseptically transfer a 0.1 and 0.25 mL aliquot to freshly prepared 16 x 125 mm screw-capped borosilicate glass Entamoeba histolytica is a pathogenic protozoan parasite that test tubes containing 13 mL of growth medium. -
The Intestinal Protozoa
The Intestinal Protozoa A. Introduction 1. The Phylum Protozoa is classified into four major subdivisions according to the methods of locomotion and reproduction. a. The amoebae (Superclass Sarcodina, Class Rhizopodea move by means of pseudopodia and reproduce exclusively by asexual binary division. b. The flagellates (Superclass Mastigophora, Class Zoomasitgophorea) typically move by long, whiplike flagella and reproduce by binary fission. c. The ciliates (Subphylum Ciliophora, Class Ciliata) are propelled by rows of cilia that beat with a synchronized wavelike motion. d. The sporozoans (Subphylum Sporozoa) lack specialized organelles of motility but have a unique type of life cycle, alternating between sexual and asexual reproductive cycles (alternation of generations). e. Number of species - there are about 45,000 protozoan species; around 8000 are parasitic, and around 25 species are important to humans. 2. Diagnosis - must learn to differentiate between the harmless and the medically important. This is most often based upon the morphology of respective organisms. 3. Transmission - mostly person-to-person, via fecal-oral route; fecally contaminated food or water important (organisms remain viable for around 30 days in cool moist environment with few bacteria; other means of transmission include sexual, insects, animals (zoonoses). B. Structures 1. trophozoite - the motile vegetative stage; multiplies via binary fission; colonizes host. 2. cyst - the inactive, non-motile, infective stage; survives the environment due to the presence of a cyst wall. 3. nuclear structure - important in the identification of organisms and species differentiation. 4. diagnostic features a. size - helpful in identifying organisms; must have calibrated objectives on the microscope in order to measure accurately. -
A Revised Classification of Naked Lobose Amoebae (Amoebozoa
Protist, Vol. 162, 545–570, October 2011 http://www.elsevier.de/protis Published online date 28 July 2011 PROTIST NEWS A Revised Classification of Naked Lobose Amoebae (Amoebozoa: Lobosa) Introduction together constitute the amoebozoan subphy- lum Lobosa, which never have cilia or flagella, Molecular evidence and an associated reevaluation whereas Variosea (as here revised) together with of morphology have recently considerably revised Mycetozoa and Archamoebea are now grouped our views on relationships among the higher-level as the subphylum Conosa, whose constituent groups of amoebae. First of all, establishing the lineages either have cilia or flagella or have lost phylum Amoebozoa grouped all lobose amoe- them secondarily (Cavalier-Smith 1998, 2009). boid protists, whether naked or testate, aerobic Figure 1 is a schematic tree showing amoebozoan or anaerobic, with the Mycetozoa and Archamoe- relationships deduced from both morphology and bea (Cavalier-Smith 1998), and separated them DNA sequences. from both the heterolobosean amoebae (Page and The first attempt to construct a congruent molec- Blanton 1985), now belonging in the phylum Per- ular and morphological system of Amoebozoa by colozoa - Cavalier-Smith and Nikolaev (2008), and Cavalier-Smith et al. (2004) was limited by the the filose amoebae that belong in other phyla lack of molecular data for many amoeboid taxa, (notably Cercozoa: Bass et al. 2009a; Howe et al. which were therefore classified solely on morpho- 2011). logical evidence. Smirnov et al. (2005) suggested The phylum Amoebozoa consists of naked and another system for naked lobose amoebae only; testate lobose amoebae (e.g. Amoeba, Vannella, this left taxa with no molecular data incertae sedis, Hartmannella, Acanthamoeba, Arcella, Difflugia), which limited its utility. -
The Revised Classification of Eukaryotes
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/231610049 The Revised Classification of Eukaryotes Article in Journal of Eukaryotic Microbiology · September 2012 DOI: 10.1111/j.1550-7408.2012.00644.x · Source: PubMed CITATIONS READS 961 2,825 25 authors, including: Sina M Adl Alastair Simpson University of Saskatchewan Dalhousie University 118 PUBLICATIONS 8,522 CITATIONS 264 PUBLICATIONS 10,739 CITATIONS SEE PROFILE SEE PROFILE Christopher E Lane David Bass University of Rhode Island Natural History Museum, London 82 PUBLICATIONS 6,233 CITATIONS 464 PUBLICATIONS 7,765 CITATIONS SEE PROFILE SEE PROFILE Some of the authors of this publication are also working on these related projects: Biodiversity and ecology of soil taste amoeba View project Predator control of diversity View project All content following this page was uploaded by Smirnov Alexey on 25 October 2017. The user has requested enhancement of the downloaded file. The Journal of Published by the International Society of Eukaryotic Microbiology Protistologists J. Eukaryot. Microbiol., 59(5), 2012 pp. 429–493 © 2012 The Author(s) Journal of Eukaryotic Microbiology © 2012 International Society of Protistologists DOI: 10.1111/j.1550-7408.2012.00644.x The Revised Classification of Eukaryotes SINA M. ADL,a,b ALASTAIR G. B. SIMPSON,b CHRISTOPHER E. LANE,c JULIUS LUKESˇ,d DAVID BASS,e SAMUEL S. BOWSER,f MATTHEW W. BROWN,g FABIEN BURKI,h MICAH DUNTHORN,i VLADIMIR HAMPL,j AARON HEISS,b MONA HOPPENRATH,k ENRIQUE LARA,l LINE LE GALL,m DENIS H. LYNN,n,1 HILARY MCMANUS,o EDWARD A. D. -
Protozoan Parasites
Welcome to “PARA-SITE: an interactive multimedia electronic resource dedicated to parasitology”, developed as an educational initiative of the ASP (Australian Society of Parasitology Inc.) and the ARC/NHMRC (Australian Research Council/National Health and Medical Research Council) Research Network for Parasitology. PARA-SITE was designed to provide basic information about parasites causing disease in animals and people. It covers information on: parasite morphology (fundamental to taxonomy); host range (species specificity); site of infection (tissue/organ tropism); parasite pathogenicity (disease potential); modes of transmission (spread of infections); differential diagnosis (detection of infections); and treatment and control (cure and prevention). This website uses the following devices to access information in an interactive multimedia format: PARA-SIGHT life-cycle diagrams and photographs illustrating: > developmental stages > host range > sites of infection > modes of transmission > clinical consequences PARA-CITE textual description presenting: > general overviews for each parasite assemblage > detailed summaries for specific parasite taxa > host-parasite checklists Developed by Professor Peter O’Donoghue, Artwork & design by Lynn Pryor School of Chemistry & Molecular Biosciences The School of Biological Sciences Published by: Faculty of Science, The University of Queensland, Brisbane 4072 Australia [July, 2010] ISBN 978-1-8649999-1-4 http://parasite.org.au/ 1 Foreword In developing this resource, we considered it essential that -
Improved Genomic Assembly and Genomic Analyses of Entamoeba Histolytica
Improved genomic assembly and genomic analyses of Entamoeba histolytica Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy by Amber Leckenby September 2018 Acknowledgements There are many people without whom this thesis would not have been possible. The list is long and I am truly grateful to each and every one. Firstly I have to thank my supervisors Gareth, Christiane, Neil and Steve for the continuous support throughout my PhD. Particularly, I am grateful to Gareth and Christiane, for their patience, motivation and immense knowledge that helped me through the entirety of the proJect from the initial research to the writing of this thesis. I cannot have imagined having better mentors and role models. I also have to thank the staff at the CGR for their role in the sequencing aspects of this thesis. My further thanks extend to the CGR bioinformatics team, most notably Richard, Matthew, Sam and Luca, for not only tolerating the number of bioinformatics questions I have asked them, but also providing great friendship and warmth in the office. I must also give a special mention to Graham Clark at the London School of Hygiene and Tropical Medicine for sending cultures of Entamoeba and providing general advice, especially around the tRNA arrays. I would also like to thank David Starns, for his efforts troubleshooting the Companion pipeline and to Laura Gardiner for providing advice around all things methylation. My gratitude goes to the members of the many offices I have moved around during my PhD, many of which have become close friends who have got me through many bioinformatics conundrums, lab meltdowns and (some equally challenging) gym sessions. -
(PCR) in Rural Communities in Malaysia Romano Ngui, Lorainne Angal, Siti Aminah Fakhrurrazi, Yvonne Lim Ai Lian, Lau Yee Ling, Jamaiah Ibrahim and Rohela Mahmud*
Ngui et al. Parasites & Vectors 2012, 5:187 http://www.parasitesandvectors.com/content/5/1/187 RESEARCH Open Access Differentiating Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii using nested polymerase chain reaction (PCR) in rural communities in Malaysia Romano Ngui, Lorainne Angal, Siti Aminah Fakhrurrazi, Yvonne Lim Ai Lian, Lau Yee Ling, Jamaiah Ibrahim and Rohela Mahmud* Abstract Background: In this study, a total of 426 human faecal samples were examined for the presence of Entamoeba histolytica, Entamoeba dispar, Entamoeba moshkovskii infection via a combination of microscopic examination and nested polymerase chain reaction (PCR) targeting 16S ribosomal RNA of Entamoeba species. Methods: Faecal sample were collected from 426 participants in five rural villages in Peninsular Malaysia. The faecal samples were processed by direct wet smear and formalin ethyl acetate concentration technique followed by iodine staining and examined via microscopy for the presence of Entamoeba species and other intestinal parasites. Microscopically positive samples for Entamoeba species cysts were further characterized using a Nested Polymerase Chain Reaction (Nested-PCR) targeting 16S-like ribosomal RNA gene. The data entry and analysis was carried out using the SPSS software (Statistical Package for the Social Sciences) program for Windows version 17 (SPSS, Chicago, IL, USA). Results: Based on single faecal examination, overall prevalence of Entamoeba infection was 17.6% (75/426). Females (19.1%) were more commonly infected compared to males (15.9%). Comparison by age groups showed that adults (23.9%) had higher infection rates than children (15.3%). The PCR results showed that 52 out of 75 microscopy positive samples successfully generated species-specific amplicons. -
Developing Novel Therapeutic Agents for Acanthamoeba Infection and Investigating the Process of Encystment
Developing novel therapeutic agents for Acanthamoeba infection and investigating the process of encystment Anas Abdullah Hamad (BSc, MSc) A thesis submitted in partial fulfilment of the requirements of the University of Wolverhampton for the degree of Doctor of Philosophy June 2020 Declaration This work or any part thereof has not previously been presented in any form to the University or to any other body whether for the purposes of assessment, publication or for any other purpose (unless otherwise indicated in page 3). Save for any express acknowledgements, references and/or bibliographies cited in the work, I confirm that the intellectual content of the work is the result of my own efforts and of no other person. The right of Anas Abdullah Hamad to be identified as author of this work is asserted in accordance with ss.77 and 78 of the Copyright, Designs and Patents Act 1988. At this date copyright is owned by the author. Signature………………………………………. Date……………………………………………. 15/10/2020 2 List of posters and publication related to the work presented in this thesis: Heaselgrave, W., Hamad, A., Coles, S. and Hau, S., 2019. In Vitro Evaluation of the Inhibitory Effect of Topical Ophthalmic Agents on Acanthamoeba Viability. Translational vision science & technology, 8(5), pp.17-17. Manuscript published. Hamad, A. and Heaselgrave, W., 2017. Developing novel treatments for the blinding protozoan eye infection Acanthamoeba keratitis. Proceedings of the Internal Annual Research Symposium, Poster no. 23, University of Wolverhampton, UK. Hamad, A. and Heaselgrave, W., 2018. Developing new treatments and optimising existing treatment strategies for the corneal infection Acanthamoeba keratitis. -
Granulomatous Meningoencephalitis Balamuthia Mandrillaris in Peru: Infection of the Skin and Central Nervous System
SMGr up Granulomatous Meningoencephalitis Balamuthia mandrillaris in Peru: Infection of the Skin and Central Nervous System A. Martín Cabello-Vílchez MSc, PhD* Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical “Alexander von Humboldt” *Corresponding author: Instituto de Medicina Tropical “Alexander von Humboldt”, Av. Honorio Delgado Nº430, San A. Martín Cabello-Vílchez, Universidad Peruana Cayetano Heredia, MartínPublished de Porras, Date: Lima-Perú, Tel: +511 989767619, Email: [email protected] February 16, 2017 ABSTRACT Balamuthia mandrillaris is an emerging cause of sub acute granulomatous amebic encephalitis (GAE) or Balamuthia mandrillaris amoebic infection (BMAI). It is an emerging pathogen causing skin lesions as well as CNS involvement with a fatal outcome if untreated. The infection has been described more commonly in inmunocompetent individuals, mostly males, many children. All continents have reported the disease, although a majority of cases are seen in North and South America, especially Peru. Balamuthia mandrillaris is a free living amoeba that can be isolated from soil. In published reported cases from North America, most patients will debut with neurological symptoms, where as in countries like Peru, a skin lesion will precede neurological symptoms. The classical cutaneous lesionis a plaque, mostly located on face, knee or other body parts. Diagnosis requires a specialized laboratory and clinical experience. This Amoebic encephalitis may be erroneously interpreted as a cerebral neoplasm, causing delay in the management of the infection. Thediagnosis of this infection has proven to be difficult and is usually made post-mortem but in Peru many cases were pre-morten. Despite case fatality rates as high as > 98%, some experimental therapies have shown protozoal therapy with macrolides and phenothiazines. -
Human Parasitology
HUMAN PARASITOLOGY FOURTH EDITION BURTON J. BOGITSH,PHD CLINT E. CARTER,PHD THOMAS N. OELTMANN,PHD AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 225 Wyman Street, Waltham, MA 02451, USA The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, UK Ó 2013 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the Publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our arrangements with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may be noted herein). Notices Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes in research methods, professional practices, or medical treatment may become necessary. Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds, or experiments described herein. In using such information or methods they should be mindful of their own safety and the safety of others, including parties for whom they have a professional responsibility. To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume any liability for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. -
Molecular Epidemiology of Human Intestinal Amoebas in Iran in Amoebas Intestinal Human of Epidemiology Molecular Iranian J Publ Health, Vol
Iranian J Publ Health, Vol. 41, No.9, Sep 2012, pp.10-17 Review Article Molecular Epidemiology of Human Intestinal Amoebas in Iran * H Hooshyar 1, P Rostamkhani 1, M Rezaian 2 1. Dept. of Parasitology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran 2. Dept. of Medical Mycology & Parasitology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran *Corresponding Author: Tel: +98 361 5550021 Fax: +98 361 5551112 (Received 16 Mar 2012; accepted 12 Jul 2012) Abstract on Tuesday, October 09, 2012 Many microscopic-based epidemiological surveys on the prevalence of human intestinal pathogenic and non- pathogenic protozoa including intestinal amoeba performed in Iran show a high prevalence of human intestinal amoeba in different parts of Iran. Such epidemiological studies on amoebiasis are confusing, mainly due to recently appreciated distinction between the Entamoeba histolytica, E. dispar and E. moshkovskii. Differential diagnosis can be done by some methods such as PCR-based methods, monoclonal antibodies and the analysis of isoenzyme typing, however the molecular study of these protozoa in Iran is low. Based on molecular studies, it seems that E. dispar is predominant species especially in the central and northern areas of Iran and amoebiasis due to E. histolytica is a rare infection in the country. It is suggested that infection with E. moshkovskii may be common among Iranians. Considering the importance of molecular epidemiology of amoeba in Iran and also the current data, the present study reviews the data currently available on the molecular distribution of intestinal human amoeba in Iran. http://journals.tums.ac.ir/ Key words: Amoeba, Entamoeba, Molecular epidemiology, Iran Introduction Downloaded from Cases of transmissions for over 18 different hu- tinal amoeba are considered non-pathogenic and man intestinal protozoa have been reported in rarely cause intestinal disease in humans (3,4).